AU2541592A - Improvements in or relating to modified haptens useful as imaging and therapeutic agents - Google Patents

Improvements in or relating to modified haptens useful as imaging and therapeutic agents

Info

Publication number
AU2541592A
AU2541592A AU25415/92A AU2541592A AU2541592A AU 2541592 A AU2541592 A AU 2541592A AU 25415/92 A AU25415/92 A AU 25415/92A AU 2541592 A AU2541592 A AU 2541592A AU 2541592 A AU2541592 A AU 2541592A
Authority
AU
Australia
Prior art keywords
imaging
relating
therapeutic agents
modified
haptens useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25415/92A
Inventor
Pavanasam N Balasubramanian
Charles P Lollo
Philip M Wanek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of AU2541592A publication Critical patent/AU2541592A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/121—Solutions, i.e. homogeneous liquid formulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
AU25415/92A 1991-08-01 1992-07-31 Improvements in or relating to modified haptens useful as imaging and therapeutic agents Abandoned AU2541592A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73962091A 1991-08-01 1991-08-01
US739620 1991-08-01

Publications (1)

Publication Number Publication Date
AU2541592A true AU2541592A (en) 1993-03-02

Family

ID=24973112

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25415/92A Abandoned AU2541592A (en) 1991-08-01 1992-07-31 Improvements in or relating to modified haptens useful as imaging and therapeutic agents

Country Status (2)

Country Link
AU (1) AU2541592A (en)
WO (1) WO1993002652A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314678A (en) * 1992-01-28 1994-05-24 Mallinckrodt Medical, Inc. Sodium iodide 131 I capsules
FR2727687B1 (en) * 1994-12-02 1997-01-24 Isotopchim Sarl STABILIZATION OF RADIOMARKED COMPOUNDS
US6027710A (en) * 1996-09-18 2000-02-22 Nihon Medi-Physiscs Co., Ltd. Radiation-protecting agent
US5961955A (en) * 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
EP1381397B1 (en) * 2000-10-24 2007-02-28 CIS bio international Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman
CN101198359B (en) * 2005-06-14 2011-06-22 日本医事物理股份有限公司 Radioactive diagnostic imaging agent
ES2369717T3 (en) * 2007-11-30 2011-12-05 F. Hoffmann-La Roche Ag STABILIZATION OF CONJUGATES UNDERSTANDING A TIOUREA CONNECTOR MOLECULE.
ES2624637T3 (en) 2008-05-30 2017-07-17 Atotech Deutschland Gmbh Electrogalvanoplasty additive for the deposition of an alloy of a metal of group IB / binary or ternary of group IB-group IIIA / ternary, quaternary or quinary of group IB, group IIIA-group VIA

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416865A (en) * 1973-02-20 1983-11-22 Research Corporation Radiopharmaceuticals for localization of thromboembolic disease
US4364920A (en) * 1975-04-30 1982-12-21 Medi-Physics, Inc. Stable diagnostic reagents
ZA761944B (en) * 1975-04-30 1977-03-30 Procter & Gamble Stable radiographic scanning agents
US4411881A (en) * 1982-07-12 1983-10-25 New England Nuclear Corporation Composition and method for stabilizing radiolabeled compounds using thiocarbonylated diethylenetriamines
CA1282069C (en) * 1985-09-12 1991-03-26 Damon L. Meyer Antibody complexes of hapten-modified diagnostic or therapeutic agents
WO1991004057A1 (en) * 1989-09-22 1991-04-04 Neorx Corporation Stable therapeutic radionuclide compositions and methods for preparation thereof
US5093105A (en) * 1991-04-09 1992-03-03 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats

Also Published As

Publication number Publication date
WO1993002652A2 (en) 1993-02-18
WO1993002652A3 (en) 1993-03-18

Similar Documents

Publication Publication Date Title
GB2220319B (en) Improvements in or relating to image stabilisation
AU655921B2 (en) Improvements in or relating to imitation weatherboarding
GB9126616D0 (en) Improvements in or relating to amplifiers
AU7789194A (en) Improvements in and relating to vaccines
GB9224807D0 (en) Improvements in and relating to footwear
GB9208761D0 (en) Improvements in and relating to cookies
GB2275029B (en) Improvements in and relating to wheelchairs
AU2541592A (en) Improvements in or relating to modified haptens useful as imaging and therapeutic agents
GB2281863B (en) Improvements in relation to medical diathermy
AU7190791A (en) Improvements in and relating to (s)-norfluoxetine
IL107726A0 (en) Pyrrole derivatives their preparation and their therapeutic use
AU4581193A (en) Improvements in and relating to dentistry
AU9159891A (en) Compositions and methods for achieving improved physiological response to exercice
AU8739591A (en) Improvements in or relating to liners
AU7540991A (en) C-5 mono-substituted barbiturates in combination with therapeutic agents and uses thereof
AU3642193A (en) Improvements in or relating to tillage elements
AU7944991A (en) Improvements in or relating to ploughs
GB9112545D0 (en) Improvements in and relating to hinges
GB2245681B (en) Improvements in and relating to fasteners
GB9114664D0 (en) Improvements in or relating to bruners
AU1633292A (en) Improvements in and relating to indicia
AU7935591A (en) Improvements in or relating to imagers
GB9200356D0 (en) Improvements in and relating to cots
GB9112733D0 (en) Improvements in and relating to raising structures
AU6562090A (en) Improvements in or relating to bags